Brigit Biofarmaka Teknologi Tbk. vs Pembangunan Jaya Ancol Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Pembangunan Jaya Ancol Tbk. trades at Rp470 (market cap 748.8B, 195.5K 24h volume). The key difference: Pembangunan Jaya Ancol Tbk. is far larger — about 4.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (324K versus 195.5K). Which is the better fit depends on your goals.
| OBAT | PJAA | |
|---|---|---|
Market Cap | 166.01B | 748.8B |
Volume | 324K | 195.5K |
Lot | 3.24K | 1.96K |
Turnover | 77.68M | 90.23M |
Average Price | 239.75 | 461.54 |
Value | 77.68M | 90.23M |
Indicative Equilibrium Price | 240 | 464 |
Indicative Equilibrium Volume | 1 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Pembangunan Jaya Ancol (Company) was established base on notarial deed No. 33 of Achmad Abid SH, dated July 10, 1992. The Company’s articles of association has been amended several times, most recently by notarial deed No. 13 of Mrs. Aulia Taufani, S.H., dated April 01, 2004.
Read more on PJAA →